A summary of mainstream reporting, plus the facts and perspectives it leaves out. A more honest account of each story.
Back to all stories
The courtroom of U.S. District Judge Hon. Brett H. Ludwig in the Federal Building during Doors Open Milwaukee 2023 in Milwaukee, Wisconsin (United States).
Photo: Michael Barera | CC BY-SA 4.0 | Wikimedia Commons

Purdue Pharma Criminal Sentence Triggers Final Phase Of Opioid Settlement

Purdue Pharma is set to be sentenced in a criminal case, a step that clears the way for its multibillion-dollar opioid settlement to move forward. A federal judge is expected to order Purdue to forfeit $225 million to the Justice Department on Tuesday under the 2020 plea deal. If the judge signs off, the government will not collect $5.3 billion in additional criminal forfeitures and fines or $2.8 billion in civil liabilities, and those sums would fold into the broader settlement.

Another judge has already approved the wider settlement, which could take effect on May 1 and requires Sackler family members to pay up to $7 billion over 15 years. Purdue pleaded guilty in 2020 to three federal criminal charges for failing to prevent drug diversion and for paying doctors and a medical records company to boost opioid prescribing. The company has already spent more than $1 billion on professional fees related to its bankruptcy reorganization, highlighting the case's complexity and cost.

Coverage has shifted from early focus on a contested bankruptcy and legal protections for the Sacklers to newer reporting that a criminal sentence could unlock settlement funds for victims. Recent reporting, led by outlets such as PBS, added concrete details about the judge's expected $225 million forfeiture order and how billions more would be folded into the approved settlement.

Opioid Litigation and Public Health Corporate Accountability and White-Collar Crime Opioid Crisis Corporate Accountability and Courts
Show source details & analysis (2 sources)

📌 Key Facts

  • A recent criminal sentence for OxyContin maker Purdue Pharma clears the way for finalizing its multibillion-dollar opioid settlement.
  • A judge is expected to order Purdue to forfeit $225 million to the Justice Department on Tuesday under the company’s 2020 plea deal.
  • If the judge signs off, the government will forgo collecting $5.3 billion in additional criminal forfeitures/fines and $2.8 billion in civil liabilities, folding those amounts into the broader settlement structure.
  • The broader settlement, already approved by another judge, could take effect May 1 and would require Sackler family members to pay up to $7 billion over 15 years.
  • Purdue pleaded guilty in 2020 to three federal criminal charges, including failures to prevent diversion and paying doctors and an electronic medical records company to drive opioid prescribing.
  • As of late last year, Purdue had spent over $1 billion on professional fees related to the bankruptcy reorganization, underscoring the case’s complexity and cost.

📰 Source Timeline (2)

Follow how coverage of this story developed over time

April 21, 2026
3:06 PM
A criminal sentence for OxyContin maker Purdue Pharma clears the way for finalizing its settlement
PBS News by Geoff Mulvihill, Associated Press
New information:
  • Confirms the judge is expected to order Purdue to forfeit $225 million to the Justice Department on Tuesday under the 2020 plea deal.
  • Details that, if the judge signs off, the government will not collect $5.3 billion in additional criminal forfeitures/fines and $2.8 billion in civil liabilities, folding those amounts into the broader settlement structure.
  • Clarifies that the broader settlement, already approved by another judge, could take effect May 1 and will require Sackler family members to pay up to $7 billion over 15 years.
  • Reiterates and contextualizes Purdue’s 2020 guilty plea to three federal criminal charges, including failures to prevent diversion and paying doctors and an electronic medical records company to drive opioid prescribing.
  • Notes that Purdue has already spent over $1 billion on professional fees related to the reorganization as of late last year, underscoring the complexity and cost of the case.